Abstract
N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure-activity relationships, and the synthesis of these inhibitors are reported herein. © 2007 Elsevier Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Deak, H. L., Newcomb, J. R., Nunes, J. J., Boucher, C., Cheng, A. C., DiMauro, E. F., … Zhu, X. (2008). N-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: Structure, synthesis and SAR. Bioorganic and Medicinal Chemistry Letters, 18(3), 1172–1176. https://doi.org/10.1016/j.bmcl.2007.11.123
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.